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Abstract 
Food-producing animals throughout the world are likely to be exposed to 
antimicrobial (AM) treatment. The crossover in AM use between human and 
veterinary medicine raises concerns that antimicrobial resistance (AMR) may spread 
from food-producing animals to humans, driving the need for further understanding 
of how AMs are used in livestock practice as well as stakeholder beliefs relating to 
their use. A Rapid Evidence Assessment (REA) was used to collate research on AM 
use published in peer-reviewed journals between 2000 and 2016. Forty-eight papers 
were identified and reviewed. The summary of findings highlights a number of issues 
regarding current knowledge of the use of AMs in food-producing animals and 
explores the attitudes of interested parties regarding the reduction of AM use in 
livestock. Variation between and within countries, production types and individual 
farms demonstrates the complexity of the challenge involved in monitoring and 
regulating AM use in animal agriculture. Many factors that could influence the 
prevalence of AMR in livestock are of concern across all sections of the livestock 
industry. This REA highlights the potential role not only of farmers and veterinarians 
but also of other advisors, public pressure and legislation to influence change in the 
use of AMs in livestock. 
 
Introduction 
Food-producing animals throughout the world are likely to be exposed to 
antimicrobial (AM) treatment. Whilst AM use may vary widely between and within 
countries, species, production systems and individual farms (Sawant and others 
2005), over the last 50 years AMs have formed a key part of animal agriculture, 
especially in the developed world (Busani and others 2004). Yet debate is growing 
over the implications for human health of using AMs in food-producing animals. The 
crossover in AM use between human and veterinary medicine has also given rise to 
concerns that resistance to AMs may be spread from food-producing animals to 
human beings. 
As a response to these concerns, national and international bodies including the 
World Health Organisation, the World Organisation for Animal Health (OIE) and the 
Food and Agriculture Organisation of the United Nations have called for AMs to be 
used responsibly and appropriately by all those who administer them. On a national 
level, guidance and legislation surrounding AM use in food-producing animals varies 
considerably (Scott and others 2015).  
In order to better understand the role that AMs currently play in human and 
veterinary medicine, recent calls have highlighted the need for improved monitoring 
of AM use, particularly in food-producing animals (Gonzalez and others 2010). 
Monitoring usage alone, however, reveals little about what is driving AM use in 
practice, such as the beliefs, motivations and activities of stakeholders involved at 
ground level, particularly farmers and their veterinarians. Such understanding is vital 
if a true assessment is to be made as to whether AMs are being used as advised 
(i.e. responsibly and appropriately), as well as to identify potential motivators and 
barriers to change in practices that may be necessary to meet these requirements.  
As part of a larger project, a Rapid Evidence Assessment (REA) was conducted to 
investigate what is currently known about the use of AMs in food-producing animals, 
encompassing their use at farm level, the practices and perceptions of the 
stakeholders involved in their administration, and the availability and validity of data 
on their use in practice. REAs are increasingly promoted as a valid alternative to 
systematic reviews of the research literature when time constraints do not allow a full 
systematic review to be undertaken, and are completed in full acknowledgement of 
the trade-off between a review being exhaustive and it being feasible to complete 
within a limited period of time (Ganam 2010; Thomas and others 2013). REAs allow 
for the comprehensive and descriptive assessment of a defined body of literature 
and, as Varker and others (2015) point out: ‘rigorous methods for locating, 
appraising and synthesizing evidence from previous studies can be upheld and 
results can be produced in a fraction of the time required for a full systematic review’. 
Moreover, REAs also ‘serve as an informative brief that prepares stakeholders for 
discussion on a policy issue (Varker and others 2015). While the application of the 
REA methodology to more qualitative and social material is generally less common 
than its use in quantitative and technological review (Thomas and others 2013), the 
increasingly acknowledged explanatory power of qualitative evidence, and its 
particular relevance here in the case of the ongoing debate over AMR, make a 
strong case for such evidence- where robustly and convincingly generated- to be 
appropriately and collectively reviewed. 
 
Materials and methods 
The validity of the REA method is in large part dependent upon the transparency of 
the process employed to identify and select papers for consideration. Consequently, 
a comprehensive description of the overall REA methodology adopted here, time 
span and search strategies are reported in Figure 1 and in the Supplementary 
Material. Although the methodology adopted and the restricted number of scientific 
publications did not allow for an exhaustive appraisal of the study design and validity 
of every study included, this was not the purpose of the REA.  
 
Results 
In total, 48 peer-reviewed papers fell within the remit of addressing current practice 
and attitudes towards AM use in food-producing animals. Highlights of the papers 
identified and general overviews are presented, by species, in the text. For a 
comprehensive summary of the papers identified by the REA, please see 
Supplementary Material. 
 
Comparison of findings by production system 
Pigs 
In some countries, the largest proportion of single-species AMs sold for food-
producing animals are intended for pigs (VMD, 2014). This may result from the fact 
that pigs are commonly treated as a group rather than as individuals (Merle and 
others 2012; Sjolund and others 2015; Sjolund and others 2016; Timmerman and 
others 2006), although individual treatments were most common in Sweden (Sjolund 
and others 2016). Furthermore, it has been suggested that a shift over the last 
decade from in-feed to in-water group treatments has led to an increase in 
antimicrobial use on pig farms (Fertner and others 2016). Across Belgium, France, 
Germany and Sweden, weaned pigs tended to have more treatments than suckling 
or finishing pigs (Sjolund and others 2016). 
 
AM use by class 
Chauvin and others (2002) noted that French pig veterinarians prescribed numerous 
AMs to pigs, often prescribing many for similar purposes. Overall, tetracyclines were 
identified as being prescribed frequently (typically for respiratory conditions), as were 
peptides (colistin), macrolides (both predominantly for enteric conditions), 
benzylpenicillins, beta-lactams, doxycycline and amoxicillin (Bashahun and Odoch 
2015; Chauvin and others 2002; Moreno 2012; Sjolund and others 2016; 
Timmerman and others 2006; van Rennings and others 2015). Fluoroquinolones and 
cephalosporins were either not used at all or used in low levels (Chauvin and others 
2002; Sjolund and others 2015; Sjolund and others 2016; Timmerman and others 
2006), and were often used as injectables administered to individual animals.  
 
AM dosing 
Considerable variation in AM use was identified, with treatment durations ranging 
from 1-21 days. The number of daily dosages (NDD) per average pig year ranged 
from 0-400, indicating that while some farms managed to rear pigs without the use of 
AMs, others exceeded the defined (registered) animal daily dose for one year (Van 
der Fels-Klerx HJ 2011). Inappropriate dosing was identified as being a common 
factor, with reports of 50-75% of oral AM formulations underdosed, and 41->90% of 
parenteral formulations overdosed (Chauvin and others 2002; Trauffler and others 
2014). 
Vaccination is often touted as an alternative to AM use in production animals, and 
one paper reported vaccination rates ranging from 11-87% (Stevens, 2007). Group 
prophylactic or metaphylactic treatments were also common (Timmerman and others 
2006). Using AMs prophylactically was considered both justifiable and prudent by 
both veterinarians and farmers (Coyne and others 2014; Stevens 2007), although 
many farmers felt that the amount of AMs used for this purpose could be reduced 
(Stevens  2007). 
 
Cattle 
Within the dairy sector, treatments for mastitis along with dry cow therapy 
administered at the end of lactation made up a large proportion of the AMs 
administered (Brunton and others 2012; Gonzalez Pereyra and others 2015; Higgins 
and others 2012; Stevens and others 2016; Swinkels and others 2015). In some 
countries, routine preventive use of AMs in all cows is forbidden, so AM dry cow 
therapy can only be used in cows with pre-existing intramammary infections 
(Swinkels and others 2015). One study comparing organic and conventional systems 
found the types of antibiotic tubes and injectables used were very similar, although 
while 85% of conventional farmers used dry cow tubes on all cows at drying off, only 
18% of organic farmers did the same (Brunton and others 2012). 
 
AM use by class 
Critically important AMs such as 3rd and 4th generation cephalosporins were used for 
mastitis extensively in the UK, Belgium and the US (Brunton and others 2012; 
Stevens and others 2016; Zwald and others 2004), but less so in Italy and 
Switzerland (Busani and others 2004; Gonzalez and others 2010; Green and others 
2010). The use of beta-lactams including penicillins, aminoglycosides, tetracyclines, 
aminocyclitols, lincomycin and trimethoprim/sulphonamide groups was reported in 
Argentinian, German, Swiss and American studies (Gonzalez Pereyra and others 
2015; Green and others 2010; Merle and others 2012).  
A small number of dairy herds in two US studies reported using AM products that are 
either explicitly prohibited for use in dairy cattle (Zwald and others 2004) or not 
recommended in food-producing animals (Cattaneo and others 2009); this practice 
was also reported in Nigeria (Ojo and others 2016). 
 
Calf treatment 
Calves appear to receive more AM treatments than older animals in dairy production 
in Sweden and Germany (Merle and others 2012; Ortman and Svensson 2004), 
although lower use was reported in calves than dairy cows in Argentina (Gonzalez 
Pereyra and others 2015). Fluoroquinolones were extensively used to treat enteritis 
in Argentina and Italy (Busani and others 2004; Gonzalez Pereyra and others 2015). 
A Swedish study (Ortman and Svensson 2004) found that 61% of farmers 
administered AM treatment without prior consultation with a veterinarian, although 
veterinarians became increasingly involved in treatment as the animals got older.  
 
AM dosing 
Treatment durations were reported to be longer for injectable preparations than for 
oral preparations (Ortman and Svensson 2004). Inappropriate dosing was reported, 
with overdosing compromising the stated withdrawal period and underdosing 
possibly acting as a risk factor for the development and spread of antimicrobial 
resistance (AMR) (Gonzalez and others 2010). Duration of mastitis treatment was 
occasionally or frequently extended beyond the duration initially specified (Swinkels 
and others 2015), and low numbers of farmers said they always completed a course 
of AMs presented for a given condition (Sawant and others 2005).  
One of the risk factors for the spread of AMR is the exposure of calves to AMs 
through the provision of antibiotic waste milk. Although this practice is commonplace 
(Brunton and others 2012; Zwald and others 2004), waste milk is not the only means 
by which calves may be exposed to AMs. Commercial milk substitute containing 
prescription antibiotics was often reported (Brunton and others 2012; Zwald and 
others 2004). 
Italian veterinarians reported often or sometimes administering AMs before the onset 
of clinical signs of diarrhoea (20%) and respiratory disease (28%), while 62% 
prescribed AMs prophylactically against mastitis at drying off, and often reported 
failure of AM treatment (Busani and others 2004).  
 
Other species  
A study into the use of antibiotics in intensive poultry farms in Uganda found that the 
majority (96.7%) of study participants frequently used antibiotics in their animals and 
that 33.3% (n=10) used antibiotics for growth promotion, furthermore it was reported 
that ‘most’ of the participants admitted to selling their products within the meat 
withdrawal times (Bashahun and Odoch 2015). Another study assessing the usage 
and practices of antimicrobial use in production animals in Nigeria surveyed 
producers farming chicken, turkey, guinea fowl, geese, duck, horse, cattle sheep, 
goat, dog, rabbit and quail. This study found that AMs were widely used in all 
production animals, and frequently used for prophylaxis, including the use of critically 
important AMs for this purpose. The use of antimicrobials banned for use in humans 
and animals was also reported (Ojo and others 2016). 
 
Attitudes, beliefs and external influences on AM use 
Factors influencing farmers’ use of AMs 
Type of production system, high production costs and an inability to reinvest in 
infrastructure were identified as factors that UK veterinarians and pig farmers felt 
influenced their AM usage, with the implication that AMs were being relied upon in 
the short term (Coyne and others 2014; Stevens 2007). Farmers who reported that 
their farm environment could be improved were significantly more likely to use in-
feed AMs for their growers and finishers than those who did not (Stevens 2007). In 
the UK, farm type was found to influence in-feed AM use, and in Austrian pig herds, 
farm type was found to impact average AM consumption (Stevens 2007; Trauffler 
and others 2014). In Austria, farm size had no significant impact on AM 
consumption, although there was an effect of the individual veterinarian on the 
therapy indication and active substance chosen (Trauffler and others 2014). In 
Belgian pig herds, a negative association was identified between biosecurity score 
and treatment incidence (based on used daily dose); fewer prophylactic AM group 
treatments were given in herds with higher biosecurity (Laanen and others 2013). 
Farmers in Nigeria also acknowledged that readily available AMs may encourage 
non-adherence to hygienic principles and management (Ojo and others 2016).  
In beef cattle, herd size and farm type (cow-calf only or multiple operation type) had 
an influence on AM use (Green and others 2010).  
A survey of dairy farmers in England and Wales found that only 17% of farmers 
would ask for veterinary advice before administering antibiotics to their animals 
(Jones and others 2015). In Ohio, over three-quarters (77%) of dairy veterinarians 
surveyed believed their clients followed protocols for AM use, while only 23% stated 
that they supplied protocols for AM use every time they prescribed them (Cattaneo 
and others 2009). Veterinarians in an Ohio-based survey also believed that their 
clients frequently used AMs without veterinary consultation (Cattaneo and others 
2009). Similar findings were reported for Pennsylvania dairy farmers (Sawant and 
others 2005) as well as Nigerian farmers (Ojo and others 2016). Farmer AM 
treatment threshold was, however found to have no correlation with the use of 
protocols or frequency of veterinary visits in US farmers from Michigan and Ohio 
(Habing and others 2016). 
Owners and managers of US feedlots perceived the expectations of many other 
members of the feedlot network (packers, retailers, consumers) to be important 
considerations in their own decision-making regarding AM use and also reported 
having a moral obligation to the cattle to treat with AMs, but degree of this perceived 
obligation varied by circumstance (McIntosh and Dean 2015). Concern for the public 
health impact due to AM use in livestock seemed to affect AM use of farmers from 
Ohio and Michigan, US, as those with more concern about this had a significantly 
higher treatment threshold in their animals (Habing and others 2016). 
Extending treatment duration for clinical mastitis was found to be a social norm 
among farmers in the Netherlands and Germany (Swinkels and others 2015). In 
addition, some farmers reported extending treatment because it made them feel like 
‘good farmers’ (Swinkels and others 2015). Danish organic dairy farmers also tended 
to perceive AMs as the treatment method with the best prognosis as well as the most 
responsible method to aid animal welfare and end animal suffering (Vaarst and 
others 2003). 
 
Farmers’ knowledge of correct AM use 
Just over half (53%) of 71 English and Welsh dairy farmers responding to a survey, 
reported knowledge of the Responsible Use of Medicines in Agriculture Alliance’s 
(RUMA) guidelines for use of AMs in cattle production in the UK, and 30% were not 
aware of concerns over the use of 3rd and 4th generation cephalosporins (Jones and 
others 2015). Furthermore, 20% of these farmers admitted that they do not always 
complete a full course of AMs as prescribed (Jones and others 2015). Spanish 
farmers are also “not very knowledgeable” about the proper use of AMs, and some 
may not be clear about the differences between curative and preventive uses 
(Moreno 2014). Approximately half (14/30) of  Ugandan farmers were not aware of 
withdrawal periods for antibiotics (Bashahun and Odoch 2015).  Farmers from 
various European countries tended to think they used AMs more judiciously and less 
frequently than their peers (Coyne and others 2014; Visschers and others 2015).  
One study identified ‘learning processes’ that farmers used to implement new health 
practices, along with the role of the veterinarian and other technical advisors who 
facilitated farmers to implement change by aiding these learning processes (Fortane 
and others 2015). 
 
Farmers’ motivation for AM use and reduction 
Just over 70% of surveyed dairy farmers from England and Wales agreed that 
reducing AM use in their herd over the next year would be a good thing, with 59% 
stating that they had the skills and knowledge to do so (Jones and others 2015). 
Restricting AM use was also considered important by 87% of Dutch dairy farmers 
(Scherpenzeel and others 2016) . Both the UK and Dutch farmers as well as farmers 
from Belgium, France, Germany, Sweden and Switzerland cited a reduced cost of 
production as the primary reason driving them to reduce AM use (Brunton and others 
2012; Jones and others 2015; Scherpenzeel and others 2016; Visschers and others 
2015). Dutch farmers also cited ‘improving public health’ as one of the most positive 
outcomes of restricting AM use (Scherpenzeel and others 2016). French pig farmers 
cited various reasons for choosing to reduce AM use, including health events, new 
economic and health strategies and ethical considerations (Fortane and others 
2015).  
 
Farmer concerns regarding AM reduction  
Over half (53%) of British pig farmers believed that AM use resulted in the production 
of increased amounts and cheaper food, and 21% indicated the use of AMs for 
growth promotion was justified (Stevens 2007). A minority (18%) of English and 
Welsh dairy farmers, however, thought that milk production would decline if they 
reduced AM use in their herds (Jones and others 2015). Spanish farmers also 
agreed that AMs play a role in enhancing performance parameters (Moreno 2014). 
Dutch dairy farmers cited uncertainty over recovery of sick cows and the number of 
sick cows as concerns regarding reduced AM use as well as additional labour 
requirements and feeling that they were being pushed to follow rules they do not 
agree with (Scherpenzeel and others 2016). In this same study, Dutch farmers 
implementing selective dry cow therapy considered ‘financial consequences’ a 
negative impact of reduced AM use less often than those using blanket dry cow 
therapy (Scherpenzeel and others 2016). 
 
Farmer attitudes towards AMR  
The threat of AMR was typically underplayed by food-producing animal stakeholders 
(Moreno 2014), with it being felt that there was insufficient evidence to decisively 
prove the link between using AMs in food-producing animals and the development of 
AMR in pathogens infecting humans (Coyne and others 2014). Most farmers from 
South Carolina that participated in one study seemed unconcerned that AM use in 
animals could lead to resistance among farm workers (Friedman and others 2007), 
while 58% of conventional farmers from Ohio and Michigan, US, disagreed that 
antibiotic use in agriculture led to resistant bacterial infections in people. In the UK, 
7% of organic farmers felt similarly (Habing and others 2016). UK farmers were 
uncertain as to whether reduced AM use on their farms would affect animal health 
and welfare or whether such a decrease would reduce AMR (Jones and others 
2015). 
 
Veterinarian attitudes towards AMR 
In the UK, veterinarians were cited as farmers’ most trusted information source 
(Jones and others 2015). The majority of Dutch and Flemish veterinarians 
responding to a survey reported to have become more aware of the need to restrict 
the use of AMs and were aiming to reduce AM use in their practice as far as possible 
(Postma and others 2016). In the US, however, a negative correlation between the 
number of years a US veterinarian had been in practice and their knowledge of AMR 
was identified (Cattaneo and others 2009). Furthermore, years qualified was 
associated with veterinarians being less concerned about AMR (Speksnijder and 
others 2015a) and more confident in their independent prescribing practice (Dean 
2011). Ohio dairy veterinarians were more likely to agree that AMR will negatively 
affect animal health (86%) than human health (63%; Cattaneo and others 2009). Key 
information sources for prescribing AMs were reported by veterinarians to be other 
veterinarians, their own personal experience, the label or leaflet accompanying the 
product, training or literature with which they were familiar, previous experience or 
the results of culture and sensitivity testing (De Briyne and others 2013; Dean 2011; 
Gibbons and others 2013; Postma and others 2016).  
 
Veterinarian motivation for prescribing 
Veterinarians in the UK, Ireland, the Netherlands and Belgium reported that 
demands from farmers, advisors or other veterinarians did influence their 
prescribing; they also felt under more pressure from legislation and public perception 
than farmers reported (Coyne and others 2014; Gibbons and others 2013; Postma 
and others 2016; Speksnijder and others 2015b). Dutch and Flemish veterinarians 
reported to have little concern over the farmers’ preference for AM product when 
prescribing (Postma and others 2016). Social pressure from other feedlot 
veterinarians and nutritionists, however, was found to have more of an influence on 
beef feedlot cattle veterinarian attitudes towards AMs; these veterinarians cited their 
highest perceived expectation for AM prescription was from pharmaceutical 
companies (Jan 2010). Their levels of trust in other relevant actors (government 
agencies, other veterinarians, etc.) also influenced their decision making (Dean 
2011). A sense of moral obligation to the public was found to be associated with a 
negative attitude to prescribing AMs (McIntosh and others 2009). The influence of 
these factors varied in different clinical situations, and social pressure (particularly 
that of colleagues and co-workers compared to, for example, nutritionists or clients) 
had more of an influence (Jan 2010). No evidence was found that veterinarians 
prescribing habits were driven by revenue or profit margin (De Briyne and others 
2013; Gibbons and others 2013; Postma and others 2016), and preserving the 
veterinary pharmacy for future years was found to be a strong motivator for Dutch 
and Flemish veterinarians to reduce AM use (Postma and others 2016).  
In the Netherlands, benchmarking that made the prescription patterns of 
veterinarians transparent was introduced in the hope of shifting social norms and 
encouraging veterinarians to self-regulate AM use (Bos and others 2015).  
 
Sensitivity testing 
The use of sensitivity testing varied widely between the European countries 
surveyed, with veterinarians reporting their decision whether to test depended on the 
animal’s response to initial therapy as well as the veterinarian’s knowledge of that 
animal or farm (De Briyne and others 2013). More rapid results and cheaper 
sensitivity testing were described to be key factors that would encourage 
veterinarians to make more use of sensitivity testing (De Briyne and others 2013). 
 
Quality of data on AM use 
It is challenging to measure on-farm AM usage due to the difficulty in obtaining an 
accurate account of the dosage and duration of treatment, with farmers often relying 
on their memory alone for recalling past treatments (Zwald and others 2004) and 
often under-reporting medicine use (Redding and others 2014). Veterinary records 
have been found to be more accurate than those of farmers, although both were 
reported to be incomplete or implausible (Gonzalez and others 2010; Merle and 
others 2012; Trauffler and others 2014). Data from the VETSTAT system in 
Denmark indicated that most of the entries from pharmacies were correct, while 
there were a high percent of errors in data originating from veterinarians and feed 
mills (Stege and others 2003).  
 
Discussion 
The 48 papers identified by the REA and summarised above highlight a number of 
issues regarding current drivers for the future use of AMs in food-producing animals. 
Table 1 summarises the key drivers of current antimicrobial use and the identified 
barriers for change, as taken from the REA. In terms of barriers to change, these 
summary findings reveal what can be interpreted as a sense of inflexibility 
particularly in the organisation of production systems and, as a consequence, in the 
potential ‘spaces’ for change, but also, though arguably to a lesser extent, in 
producer sensibilities around the nature of good husbandry. There is also, however, 
a clear indication that amongst respondents to the various surveys reviewed, there is 
both an awareness of the issue and a willingness to explore the potentials for 
change in antimicrobial use. 
The huge variation between and within countries, production types and individual 
farms demonstrates the complexity of the challenge involved in monitoring and 
regulating AM use in animal agriculture.  
The sample sizes and associated response rates in these studies illustrates the 
difficulties in recruiting participants for AM research, and should be taken into 
account when interpreting results. Other challenges include concerns about the ease 
of comparing the findings of studies across methodologies, countries and production 
systems. While some papers report AM product names, others use classes or active 
substances to categorise AMs. Complexity increases when the amount of AMs used 
is considered. A document published by the European Medicines Agency in 2015 set 
out principles for the calculation of defined daily dose for animals (DDDvet) and 
defined course dose for animals (DCDvet) as a veterinary equivalent to the defined 
daily dose developed for human medicine, taking medicine potency into account 
(EMA 2015). These methods are not globally recognised, however, and there 
remains a variety of different usage measures or dosage calculations included in the 
literature (Gonzalez and others 2010; Moreno 2012; Taverne 2015; Timmerman and 
others 2006).  
Over half of the papers included in this REA reported research conducted within the 
EU. This may reflect the greater regulation of AM use in this region compared to 
other parts of the world (Scott and others 2015). The research question addressed 
by this REA focused particularly on pigs, poultry and cattle, yet only two papers on 
AM use in poultry could be identified for inclusion, suggesting a deficit of published 
peer-reviewed research in the poultry sector. The majority of papers identified in this 
REA instead covered AM use in pigs and cattle. Only one study performed within the 
EU made reference to AM use by a food-producing animal other than pigs and cattle, 
highlighting the impact of a few prescriptions for quinolones used in aquaculture on 
kilograms of AMs distributed per month by Danish pharmacies, due to the quantities 
prescribed (Stege and others 2003). Given the expanding global aquaculture 
industry, research into current AM use and beliefs in this sector should also be a 
priority. 
There are a number of limitations of conducting an REA rather than an exhaustive 
systematic review, including biases relating to publication, language and 
accessibility, although these are not unique to REAs (Thomas and others 2013). 
Nonetheless, this work demonstrates the valuable contribution of the REA 
methodology to research when rapid insight into the current status of research in a 
given area is needed. 
 
Conclusions 
Multiple factors which could influence the prevalence of AMR in livestock species - 
including the improper use of AMs in both the pig and cattle sectors, across all global 
regions - remain a concern. Prophylactic and metaphylactic use of AMs appears to 
be common practice across all sectors for which relevant literature was found, 
largely pig and cattle production within EU countries, but also other sectors 
worldwide. Literature regarding the use of AMs in poultry production in the EU in 
particular was lacking from the searches. It is likely that data regarding AM 
consumption in poultry production are collected by poultry producers in some 
countries but these data are not available in the published literature. Work should 
therefore be done to amalgamate and publish any existing data or investigate this 
area of AM use further. Levels of farmer knowledge with regard to proper and 
prudent use of AMs varies between groups, although veterinary input regarding the 
treatment of animals was, on the whole, low across all geographical locations.   
Economic concerns and restraints relating to farm infrastructure or production type 
may limit farmers’ ability or motivation to alter AM use in their animals. Veterinary 
advice, public pressures, input from other advisors and moral obligation influence 
farmers’ attitudes to AM use. Similarly, veterinary prescribing habits have been 
shown to be influenced by similar factors to differing degrees, and veterinarians’ 
confidence in their own knowledge of the AMs they are prescribing also influence 
prescribing behaviour. It would stand to reason, therefore, that increasing knowledge 
of the proper use of AMs as well as awareness of AMR and encouraging a reduction 
in AM use in all of these sectors is necessary, and this could have synergistic effects 
when compared to strategies targeting only one group of actors.  
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Figure 1. PRIMSA flow diagram illustrating the selection process for the final 48 
articles (Moher and others 2009)  
Table 1. Identified key drivers and barriers to change of antimicrobial use in food-
producing animals 
Table 1. Identified key drivers and barriers to change of antimicrobial use in food-
producing animals 
Identified drivers in reducing antimicrobial use 
Higher levels of on-farm biosecurity lead to lower prophylactic use 
New methods of knowledge exchange and learning improve farmer awareness of and response to 
more sensible antimicrobial use 
Reducing costs of production would encourage reduced antimicrobial use 
Farmers recognise and acknowledge the need to reduce antimicrobials 
Veterinarians in general support antimicrobial use reduction 
No evidence exists that medicine sales by veterinarians are a factor driving overuse of 
antimicrobials 
Better diagnostics or wider use of diagnostics would improve the ability to use medicines more 
effectively 
Wider use of vaccines to prevent disease would reduce antimicrobial use 
Identified barriers to more sustainable use 
Production system inflexibility hinders reduction in antimicrobial use 
High production costs reduce capacity for antimicrobial use reduction 
Low capacity for reinvestment in farm buildings reduces capacity for reduction in antimicrobial use 
Farmer concern over being a ‘good’ farmer hinders reduces antimicrobial use 
Farmer concern for welfare and health of animals leads to a reluctance to reduce antimicrobial use 
Farmer failure to follow treatment guidelines leads to over- or under-dosing of antimicrobials 
Farmer belief that antimicrobial use will improve profitability hinders reduction in antimicrobial use 
Veterinarians are under pressure from farmers, feed suppliers and others to use antimicrobials 
Changes in antimicrobial use in feed regimes (e.g. from feed to water) represents potential for 
increased antimicrobial use 
Farmers initiating treatment without seeking veterinary advice leads to inappropriate use of 
antimicrobials 







 Supplemental materials 
Search strategy 1 
The large number of references identified from the MEDLINE and CAB Abstracts 
searches were exported to EndNote Web (Thomson Reuters, NY, USA) to facilitate 
their management as well as simplify the identification and removal of duplicates. 
The search terms used and the number of references identified are summarised in 
Table 2. Search strings for each database were developed with the assistance of a 
subject librarian, making use of each database’s own subject headings and 
categorisation of keywords. Search strings were kept as broad as possible, and the 
references identified in retrieved papers were also searched manually, as this was 
considered preferable to narrowing down the search parameters too far and risking 
missing key papers. 
[Table 2 here] 
Search strategy 2 
The second search strategy included keyword internet searches, using, for example, 
Google Scholar, the results of keyword alerts set up for a number of journals and 
internet search engines, direct searches of significant journal databases (The 
Veterinary Record and Preventive Veterinary Medicine were identified as key 
sources of highly relevant papers, as these identified 93 and 316 records 
respectively) as well as identifying papers through the reference lists of manuscripts 
previously identified as highly relevant to the research question.  
The combined search strategy initially identified 4,014 papers. Once duplicates and 
irrelevant articles were removed, 134 articles remained, from which a ‘long list’ of 
114 articles were selected for further consideration, according to their relevance to 
the research question. From this ‘long list’, a final selection of 29 papers was made. 
When the searches were repeated in March and October 2016, a further 418 and 69 
papers, respectively, were initially identified, of which 383 and 67 were considered to 
meet the initial criteria. A long list of 35 (March) and 14 (October) papers was 
produced before a final 13 and 7 were chosen to be included in the selection from 
which the following analysis is derived. 
For both search strategies, basic inclusion criteria were that studies must have been 
published in a peer-reviewed English-language journal between 2000 and 2016 
(taken as present at the time of searching). The full text article was also required to 
be electronically accessible to the authors.  
Figure 1 illustrates the flow of information from the identification of papers to the 
selection of those included in the REA, using the PRISMA reporting guidelines for 
systematic reviews and meta-analyses (Moher and others 2009). 
[Figure 1 here] 
Initially two researchers (HB, JH) independently screened all papers and assessed 
the eligibility of those put forward. The same two researchers also met face-to-face 
to discuss decisions on inclusion of papers in order to reach agreement on which 
studies would ultimately be included in the REA. A third researcher (AT) then 
performed the additional searches and the final selection of these papers was made 
with the consultation and guidance of the initial two researchers.  
 Table 2. Search terms used in the three database searches undertaken and the outcomes of these searches 
   Searched  
29.1.15 – 2.2.15 
Searched  


























MEDLINE         
 Poultry AND Antimicrobial  258 208 19 15 0 0 223 
 Dairy AND Cattle AND Antimicrobial  453 401 10 4 0 0 405 
 Swine AND Antimicrobial  1653 1268 19 9 0 0 1277 
CAB Abstracts          
 Antimicrobial/Antibacterial AND 
Livestock 
  1371 153 134 9 9 1506 
 Antimicrobial/Antibacterial AND 
Attitudes 
 176 160 25 18 3 3 178 
 Antimicrobial/Antibacterial/Antibiotics 
AND Attitudes AND Livestock 
  5 4 4 3 2 9 
 Antimicrobial/Antibacterial AND 
Farmers/Farmers attitudes AND 
Livestock 
  26 5 5 3 3 30 
 Antimicrobial/Antibacterial/Antibiotics 
AND Farmers/Farmers attitudes 
 179 141 45 43 13 13 184 
 Antimicrobial/Antibacterial/Antibiotics 
AND Prophylaxis AND Livestock 
 37 15 8 8 1 1 23 
 Antimicrobial/Antibacterial AND 
Surveillance AND Livestock 
 34 31 6 6 4 4 37 
 Antimicrobial/Antibacterial/Antibiotics 
AND Vets 
 470 339 97 78 7 7 417 
 Antimicrobial/Antibacterial/Antibiotics 
AND Vets AND Livestock 
  49 27 23 26 25 75 
    4014  383  67 2423 
ͣ Papers published in peer-reviewed English-language journals between the years 2000-2016 (taken as present at time of search)





































Dairy cows On-farm AM use and waste 
milk feeding practices 









Pigs AM use and prescribing 
behaviour of pig farmers 
and pig vets 
Focus groups of pig 
farmers and pig vets 
26 (17 farmers, 
9 vets) 
No No 




Cattle (mixed) AM prescribing behaviour 




(author present during 
completion) 
118 vets (66%) No No 




Dairy cows Veterinary beliefs regarding 




24 vets (from 5 
practices) 
No No 




Dairy cows Producer opinions in AM 
use in Dairy cows 
Postal survey of dairy 









Pigs AM use on commercial pig 
farms 















































Letter  No No 




Cattle (mixed) Knowledge, attitudes and 
practices of cattle vets 
regarding AMs 
Telephone survey of 
cattle vets in private 
practice 
106 vets (70%) Yes No 




Pigs Group-level AM 
prescriptions by pig vets 
Postal survey of pig 
vets 
303 vets (70%) Yes Yes 






AM prescribing behaviour 
of companion, farm and 
equine vets in Europe 
Online survey for vets 









Pigs Changes in group 
treatment procedures and 
influence on AM use 
Data from Central 
Husbandry register 
and VetStat system 
724 farms No Yes 




Pigs Producer learning 
processes – AM use 
Semi-structured 
interviews 
21 farmers No No 




Calves Treatment thresholds and 
AM alternatives among calf 
producers 
Postal survey of calf 
rearers 
727 farmers No No 




Pigs Biosecurity, production and 
AM treatment on pig farms 










Dairy cows AM use on dairy farms Farm visit, farmer 
interview and records 
detailing future AM 
treatment requested 












Feasibility study for 
monitoring AM use in cattle 
and pigs 











Pigs AM use in farrow-to-finish 






and 67 (67%) 
finisher farmers 
Yes Yes 




Pigs Producer opinions on AM 





























Opinions of veterinarians 
on AM use in farm animals 
Postal survey of farm 
animal vets 
174 Flemish 











of treatments and 
delivery of animal 
drugs to farms 





Dairy Cows Attitudes of Dutch dairy 
farmers on reduced AM 
use 
Postal survey and 
milk recording data 
177 farms No No 




Pigs Antimicrobial use in 
Swedish pig herds 
On farm drug 
administration records 








Pigs Antimicrobial usage 
patterns in farrow-to-finish 
pig herds in Belgium, 
France, Germany and 
Sweden 












Attitudes and perception of 
Dutch veterinarians on their 
role in reducing AM use in 
farm animals 






 Determinants of Dutch vets 
AM prescribing habits. 
Semi-structured 
interviews 
11 farm animal 
vets 
No No 








The Danish surveillance 
system for AM use in 
production animals 
Data taken from 
VETSTAT system 
N/A Yes No 




Dairy cows Quantification of AM 
consumption in Dairy herds 
in Belgium 
“Garbage can audits” 
of Belgian Dairy herds 





Dairy cows Social influences on farmer 
regarding AM treatment of 
clinical mastitis 
Semi-structured 








Pigs Influence of applying 
different units of 
measurement on reporting 
AM consumption data for 
pig farms 
Analysis of data 
reported to the 
Netherlands 
Veterinary Medicines 
Authority for the pig 
sector in 2012 





Pigs Quantification of AM group 
treatments for fattening 
pigs 
Farm visit. Treatment 
records collected 
retrospectively 
50 herds (60%) Yes Yes 




Pigs Plausibility check of on-
farm records of AM use 
Data from electronic 
on-farm record 
system 













20 farms No No 
Van der Fels-Klerx 
and others 2014 
Iterative 
search 
Pigs Farm-factors associated 
with use of AM in pig 
production 
Data collected from 
farms as part of a 
larger project were 
used for this study 




and 63 farms + 
155 farm year 







Pigs Perceptions of producers 
regarding AM usage, 
resistance and policy 
measures 






ͣThese studies used data generated by the same face-to-face questionnaire






































Poultry Assessment of antibiotic 
usage in intensive poultry 




drug sellers and 
veterinary officers 










Dairy cows Knowledge, beliefs and 
practices of cattle vets 
regarding AM resistance 
Survey administered 
online and by post  
43 vets (26%) No No 




Beef cattle Role of trust and moral 
obligation regarding AM 
metaphylaxis 
recommendations 
Postal survey of vets 
with beef feedlot 
clients 





Dairy cows Pilot study exploring farmer 
knowledge, attitudes and 
practices regarding AM use 
Survey completed by 
cognitive interviewing. 
Four focus group 
sessions also 
conducted 
42 farmers from 
34 farms (20 
interviewed in 
person, 22 took 











Quantification of AM use Data from on-farm 
records 
18 Dairy farms 
of 50 meeting 
the criteria, 11 
calf rearing units 
of 11 meeting 
the criteria. 
Yes Yes 




Beef cattle Farmer attitudes and 
practices regarding AM use 









Beef cattle Influence of moral 
obligation and subjective 
norms on vets’ use of AM 
Postal survey of vets 
with beef feedlot 
clients 





Beef cattle Vets’ moral and 
instrumental beliefs 
regarding AM use 
Postal survey of vets 
with beef feedlot 
clients 





Beef cattle Perceptions of feedlot 
owners, managers and vets 
regarding AM use 
Postal survey of vets 
with beef feedlot 
clients and feedlot 
owners and 
managers 
103 vets (42%) No No 






AM usage and practices 
among livestock producers 






454 producers Yes No 




Dairy cows Comparison of two on-farm 
methods for collecting data 
on AM use  
Farmers asked to 
keep all packaging 
from all AMs used on-
farm and this was 
compared to AM use 
reported in an 
interview  
17 (85%) of 
recruited farms 
adhered to the 
protocol 
Yes Yes 




Dairy cows AM use in dairy herds Survey administered 
face-to-face. Part 1 
completed by all 
farmers and Part 2 
only by those who 
kept records of AM 
use 
113 farmers (33 








Dairy cows Management practices and 
reported AM use on 
conventional and organic 
dairy farms 
Farm visit during 
which a survey was 
administered, 
interview conducted 
and tour taken 
131 farmers Yes No  
1These studies used data generated by the postal survey 
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Context 
Food-producing animals are often exposed to antimicrobial (AM) treatment, raising 
concerns that antimicrobial resistance (AMR) may spread from food-producing 
animals to humans. There is thus a need to understand how AMs are used in 
livestock as well as stakeholder beliefs regarding their use. Such understanding is 
vital for a true assessment to be made of whether AMs are being used as advised 
(i.e. responsibly and appropriately) as well as to identify potential motivators and 
barriers to change in prescribing and administration. 
Main conclusion 
Variation between and within countries, animal production systems and individual 
farms demonstrates the complexity of the challenge involved in monitoring and 
regulating AM use. Factors that influence the prevalence of AMR in livestock are of 
concern across all sectors. This Rapid Evidence Assessment (REA) highlights the 
potential role not only of farmers and veterinarians but also other advisors, public 
pressure and legislation to influence change in the use of AMs in livestock. 
Approach 
An REA was conducted to investigate current knowledge regarding the use of AMs 
in food-producing animals, encompassing their use at farm level, the practices and 
perceptions of the stakeholders involved in their administration, and the availability 
and validity of data on their use. Publications in peer-reviewed journals between 
2000 and 2016 were included. 
Results 
Forty-eight papers addressing current practice and attitudes towards AM use in food-
producing animals were identified and reviewed. Table 1 summarises the key drivers 
of current AM use and the identified barriers for change.  
[Table 1 here] 
The summary of findings highlights a number of issues regarding current knowledge 
of the use of AMs in food-producing animals and explores the attitudes of interested 
parties regarding the reduction of AM use. Multiple factors which could influence the 
prevalence of AMR in livestock species - including the improper use of AMs across 
all global regions - remain a concern. Prophylactic and metaphylactic use of AMs 
appears to be common across all sectors for which relevant literature was found: 
largely pig and cattle production within EU countries but also other sectors 
worldwide. Peer-reviewed literature regarding use of AMs in poultry production in the 
EU in particular was lacking. In some geographical regions AMs are prescribed and 
administered by veterinarians; in others, AMs are prescription only medicines but 
some on-farm treatment decisions rest with farm staff, but in many regions AMs are 
not under strict veterinary control. This may lead to inadequate levels of veterinary 
input regarding the treatment of animals across some geographical areas and animal 
production systems. Economic concerns and restraints relating to farm infrastructure 
or production system may limit farmers’ ability or motivation to alter AM use. 
Veterinary advice, public pressure, input from other advisors and moral obligation 
influence farmers’ attitudes to AM use. Veterinary prescribing habits have been 
shown to be influenced by similar factors, and veterinarians’ confidence in their 
knowledge of the AMs they prescribe also influences prescribing behaviour. 
Interpretation 
In terms of barriers to change, these summary findings reveal a sense of inflexibility 
particularly in the organisation of production systems and, as a consequence, in the 
potential ‘spaces’ for change. Producer sensibilities about the nature of ‘good 
husbandry’ may also inhibit change. There is a clear indication that amongst 
respondents to the various surveys reviewed, both an awareness of the issue and a 
willingness to explore the potentials for change in AM use exists. The huge variation 
between and within countries, production systems and individual farms demonstrates 
the complexity of the challenge involved in monitoring and regulating AM use. Use of 
the REA methodology makes a valuable contribution when rapid insight into the 
current status of research is needed. 
Significance of findings 
Awareness of the threat of AMR is variable, as is understanding of the role that AM 
use in livestock may play in AMR selection and transmission. Furthermore, barriers 
to change in AM use practices have been identified. Increasing knowledge and 
understanding of proper and prudent use of AMs held by all those involved in 
livestock production could have empowering and synergistic effects for the reduction 
of AMR when compared to strategies targeting only one group. 
